- Previous Close
2,514.85 - Open
2,510.00 - Bid --
- Ask --
- Day's Range
2,465.00 - 2,541.00 - 52 Week Range
2,165.80 - 3,653.95 - Volume
101,664 - Avg. Volume
234,927 - Market Cap (intraday)
209.693B - Beta (5Y Monthly) 0.26
- PE Ratio (TTM)
50.26 - EPS (TTM)
50.05 - Earnings Date May 8, 2025 - May 12, 2025
- Forward Dividend & Yield 36.00 (1.43%)
- Ex-Dividend Date Feb 5, 2025
- 1y Target Est
3,105.42
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.
www.lalpathlabs.com4,099
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: LALPATHLAB.NS
View MorePerformance Overview: LALPATHLAB.NS
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LALPATHLAB.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LALPATHLAB.NS
View MoreValuation Measures
Market Cap
209.62B
Enterprise Value
200.00B
Trailing P/E
50.23
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.72
Price/Book (mrq)
10.47
Enterprise Value/Revenue
8.32
Enterprise Value/EBITDA
26.42
Financial Highlights
Profitability and Income Statement
Profit Margin
17.34%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
24.04B
Net Income Avi to Common (ttm)
4.17B
Diluted EPS (ttm)
50.05
Balance Sheet and Cash Flow
Total Cash (mrq)
11.27B
Total Debt/Equity (mrq)
9.75%
Levered Free Cash Flow (ttm)
--